This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of NAYZILAM 5 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $1,008.39 and an ultimate completion date of April 17, 2024. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.52 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $2,173.25 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NAYZILAM 5 MG NASAL SPRAYS. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, a $1,008.39 firm fixed price delivery order contract to supply 4564168540 units of the specialty pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,991.77 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG nasal sprays, with a completion date of December 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,680.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $4,279.97 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. As a major supplier...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,827.83 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of April 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $1,344.52 and is a firm fixed-price delivery order with a final completion date of November 8, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide NAYZILAM 5 MG NASAL SPRAYS. The total potential value of this order is $5,464.01, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this contract, which does not have a set-aside designation. Amerisourcebergen Drug Corp has an indefinite delivery...